q2 adjusted earnings per share $1.05.
q3 revenue $37.9 million versus refinitiv ibes estimate of $4.48 billion.
qtrly scientific revenue increased 16% year-over-year.
qtrly organic revenue declined 4.3% year-over-year.
q2 revenue rose 31.2 percent to $60.1 million.
q3 revenue $22.8 million versus refinitiv ibes estimate of $1.61 billion.